|
Asbestos & Mesothelioma Headlines
More Asbestos News
Asbestos
victims take campaign to Hardie investors
ABC Online - Sept,
2004
Cuyahoga
County Limits Asbestos Court To Those Who Are
Sick
NewsNet5.com, OH - Sept.,
2004
Asbestos
death link
News Shopper, UK -
Sept, 2004
AN ELDERLY widow's death could be linked to
asbestos fibres on the clothes of her son who
died four years ago, according to an inquest.
Treatment
guides issued for asbestos-related disease
American Medical News -
Sept, 2004
The American Thoracic Society published a guide
for physicians who are treating nonmalignant
diseases related to exposure to asbestos.
University
of Iowa settles Old Capitol lawsuit for $1.9
million
Waterloo Cedar Falls
Courier, IA - Sep 25, 2004
... 31, 2003, claiming negligence and breach of
contract by workers who used open flame torches
to remove asbestos from portions of Old Capitol.
Asbestos
delaying renovation project at Fox hospital
Oneonta Daily Star, NY - Sep
24, 2004
... needs to be demolished, hospital spokeswoman
Maggie Barnes said in May. Before that can be
done, however, asbestos needs to be removed from
the building.
Asbestos
blamed in project tie-ups
Boston Globe, MA - Sep
23, 2004
... The demolition, which was supposed to be
completed during the summer, has not gone
smoothly, as workers have discovered asbestos in
many more places than...
Hope
for mesothelioma sufferers
Ninemsn, Australia - Sep
22, 2004
The word mesothelioma sparks fear into potential
cancer patients and anger in asbestos sufferers.
Long seen as a veritable death ...
Canada
blocks asbestos type from global toxic list
Planet Ark, NY - Sep
21, 2004
WASHINGTON - Canada has blocked the addition of
a carcinogenic type of asbestos to a global list
of toxic chemicals, a move that
environmentalists said this ...
GM
settled ex-worker's asbestos suit
The St. Louis
Post-Dispatch, MO - Sep 21, 2004
... A few months later, Bryson got his lungs
tested at a screening for asbestos diseases held
at his union hall. The test disclosed ...
New
Mesothelioma Treatments
Press World (press
release), Russia - Aug 25, 2004
(EMAILWIRE.COM, August 25, 2004) Woodland Hills,
CA—Mesothelioma Advisor ( http://www.mesothelioma-advisor.org
) has released a report on new mesothelioma ...
Condesa
Launches Blawg Republic
PR Leap (press release),
CA - 9 hours ago
... oriented online news service and Asbestos
Today (http://www.asbestostoday.com/), an online
service that aggregates the latest asbestos and
mesothelioma news. ...
02/05/2004
FDA Approves First Drug for Rare Type of
Cancer
The Food and Drug Administration (FDA) today
approved Alimta (pemetrexed disodium) for use in
combination with cisplatin for the treatment of
patients with malignant pleural mesothelioma-a
rare type of cancer. Alimta received a priority
review and is designated as an orphan drug. It
is the first drug approved for this condition.
Cancer of the mesothelium, a membrane that
covers and protects most of the internal organs
of the body is rare; about 2,000 new cases are
diagnosed in the United States each year. This
form of cancer is usually associated with a
history of asbestos exposure. Asbestos fibers
lodged in the lung attach to the outer lung
lining and chest wall, causing tumors to grow.
By the time symptoms appear, the disease is
usually advanced, and patients live, on average,
nine to thirteen months following diagnosis.
>
Read full FDA release
--------------------------------------------------------------------------------
02/2004
Study Supports Development Potential in Several Therapeutic Areas
The study, titled, "Autocrine inhibitory influences of alpha-melanocyte-stimulating hormone in malignant pleural mesothelioma," might provide a novel strategy to reduce mesothelioma cell proliferation.
> Read Full News Article
> Read Abstract for New Study
--------------------------------------------------------------------------------
11/2003
Pacific Northwest Research Institute reported the development of a blood test for mesothelioma.
Seattle-Researchers at the Pacific Northwest Research Institute (PNRI) have reported the development of a blood test for mesothelioma, a highly aggressive lung cancer caused by asbestos exposure.
A PNRI team led by Dr. Ingegerd Hellstrom, and an Australian team, led by Dr. Bruce Robinson, of the University of Western Australia, conducted the research, which appears in the November 15th issue of Lancet. The new test promises a simple technique for diagnosing and monitoring mesothelioma early in its progress, when therapy is more likely to be successful. Fujirebio Diagnostics, Inc. (FDI) of Malvern, PA, a leading oncology diagnostic company, has acquired an exclusive license from PNRI to develop a commercial test for worldwide distribution.
> Read Full News Article
|
